Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway-Reference-Cited by-同舟云学术

Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway

Published:2015-06-16 Issue:4 Volume:41 Page:385-393
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Chaabane Souhir,Marzouk Sameh,Akrout Rim,Ben Hamad Mariem,Achour Yosser,Rebai Ahmed,Keskes Leila,Fourati Hela,Bahloul Zouhir,Maalej Abdellatif

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13318-015-0288-z.pdf

Reference56 articles.

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356–61.

2. Smolen JS, Landewe´ R, Breedveld FC, Buch M, Burmester G, Dougados M, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease- modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73:492–509.

3. Rath T, Rubbert A. Drug combinations with methotrexate to treat rheumatoid arthritis. Clin Exp Rheumatol. 2010;28(5 Suppl 61):S52–7.

4. Johnsen AK, Weinblatt ME. Methotrexate. In: Hochberg MC, Silman AJ, Smolen JS, editors. Rheumatology. 5th ed. Philadelphia: Mosby-Elsevier; 2011. p. 509–18.

5. Peters GJ, Hooijberg JH, Kaspers GJ, Jansen G. Folates and antifolates in the treatment of cancer; role of folic acid supplementation on efficacy of folate and non-folate drugs. Food Sci Technol. 2005;16(6–7):289–97.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of genetic polymorphism on toxicity and pharmacokinetics of methotrexate in Egyptian adult patients with leukaemia or lymphoma;Xenobiotica;2024-02-07

2. The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients;Clinical Rheumatology;2024-02-05

3. MTHFR and MTRR Genetic Polymorphism of Methotrexate Therapy Outcomes in Early Rheumatoid Arthritis;Pharmacogenomics and Personalized Medicine;2023-05

4. DPYD and TYMS polymorphisms as predictors of 5 fluorouracil toxicity in colorectal cancer patients;Journal of Chemotherapy;2022-09-22

5. Capturing the Catalytic Proton of Dihydrofolate Reductase: Implications for General Acid–Base Catalysis;ACS Catalysis;2021-04-28